Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Authors including 'He_M'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
FELLOWS EJ, BERNHEIM F The effect of a number of aralkylamines on the oxidation of tyramine b... J Pharmacol Exp Ther 1950
Delay J, Lhermitte F, Ver... Modifications de l'électrocorticogramme du lapin par la diéthylamide d... Rev. Neurol. 1952
Herxheimer H The 5-hydroxytryptamine shock in the guinea-pig. J. Physiol. 1955
Herxheimer H Bronchoconstrictor agents and their antagonists in the intact guinea-p... Arch. internat. phar... 1956
Wilhelmi G Ueber die ulcerogene Wirkung von 5-hydroxytryptamin am Rattenmagen und... Helvet. physiol et. ... 1957
Heim R, Brack A, Kobel H,... Déterminisme de la formation des carpophores et des sclèrotes dans la ... Compt. rend. Acad. s... 1958
Heim R, Hofmann A Isolement de la Psilocybine à partir du Stropharia cubensis Earle et d... Compt. rend. Acad. s... 1958
Delay J, Pichot P, Lempér... Effets psycho-physiologiques de la Psilocybine Comptes rendus des s... 1958
Hofmann A, Heim R, Brack ... Psilocybin ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Rev. Mycologie 1958
Hofmann A, Heim R, Brack ... La Psilocybine, Principe Actif Psychotrope Extrait Du Champignon Hallu... Les chamignones hall... 1958
Heim R, Brack A, Kobel H,... Déterminisme de la formation des carpophores et des sclèrotes dans la ... Rev. Mycologie 1958
Heim R, Brack A, Kobel H,... Déterminisme de la formation des carpophores, et éventuellement des sc... Let champignons hall... 1958
Heim R, Hofmann A Isolement de la psilocybine à partir du Stropharia cubensis Earler et ... Rev. Mycologie 1958
Wilhelmi G, Schindler W Ueber die gastrotrope Wirkung von 5-Hydroxytryptamine (HTA), seiner Vo... Arch.exper.Path.Phar... 1959
Starbuck WC, Heim HD Some in vitro effects of chlorpromazine, lysergic acid diethylamide, a... J. Amer. Pharm. Ass.... 1959
Hofmann A, Heim R, Brack ... Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen... Helv. chim. Acta 1959
Heimann H Ausdrucksphanomenologie der Modellpsychosen (Psilocybin): Vergleich m... Psychiatria et Neuro... 1961
H Heimann Zur Behandlung therapieresistenter Neurosen mit Modellpsychosen (Psilo... Schweiz. Arch. Neuro... 1962
Heimann H Zur Behandlung therapieresistenter Neurosen mit Modellpsychosen (Psilo... Schweizer Archiv für... 1962
Heimann H Beobachtungen über gestörtes Zeiterleben in der Modellpsychose Schweiz. med. Wschr. 1963
Heimann H Die wirkung von ololiuqui im unterschied zu psilocybin Neuro-Psychopharmaco... 1965
Heimann H Die quantitative Analyse mimischer Bewegungen und ihre Anwendung in de... Arzneimittel-Forsch. 1966
Ruckebusch Y, Roche M, Sc... Parallélisme des effets des psychodysleptiques majeurs sur la toxicité... C.R. Soc. Biol. 1966
M Gyorgy Miklos Ola'h, He... Etude Chimiotaxinomique sur les Panaeolus. Recherches sur la presence ... C R Acad Sci 1968
Cheymol J Historique des hallucinogènes Laval Méd. 1969
Roche M Etude comparée des effets centraux des psychodysleptiques chez de lapi... C.R. Soc. Biol. 1970
Roche M Privation sensorielle et activité psychodysleptique C R Soc BIol (Paris) 1970
Heimann H Psychopharmakologie und Verhalten Fortibildungskurse d... 1971
Herman ZS 5-Hydroxytptamine Metabolism in the Brain Under the Influence of Psych... Pol.J.Pharmacol.Phar... 1975
Chekman IS, Potemkina NN,... Nicotinamide Coenzymes as the Object of Action of Medicines and poison... Farmakol.Toksikol. 1977
Heym J, Steinfels GF, Jac... Medullary serotonergic neurons are insensitive to 5-MeoDMT and LSD European Journal of ... 1982
Jacobs BI, Heym J, Rasmus... Action of Hallucinogenic Drugs at Postsynaptic Serotonergic Receptors Psychopharmacology B... 1982
Glennon RA, Misenheimer B... Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... Pharmacol Biochem Be... 1989
Hekmatpanah CR, McKenna D... Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... Neurosci Lett 1989
Glennon RA, Misenheimer B... Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopr... Pharmacol Biochem Be... 1989
Glennon RA, Misenheimer B Stimulus properties of a new designer drug: 4-methylaminorex ('U4Euh') Pharmacol Biochem Be... 1990
Hekmatpanah CR, Peroutka ... 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... Eur J Pharmacol 1990
Hermle L, Funfgeld M, Oep... Mescaline-induced psychopathological, neuropsychological, and neuromet... Biol Psychiatry 1992
Gouzoulis E, Steiger A, E... Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in ... Biol Psychiatry 1992
Helmlin HJ, Brenneisen R Determination of psychotropic phenylalkylamine derivatives in biologic... J Chromatogr 1992
Gouzoulis E, Borchardt D,... A case of toxic psychosis induced by 'eve' (3,4-methylene-dioxyethylam... Arch Gen Psychiatry 1993
Hermle L, Spitzer M, Borc... Psychological effects of MDE in normal subjects. Are entactogens a new... Neuropsychopharmacol... 1993
Hermle L, Spitzer M, Borc... Psychological effects of MDE in normal subjects. Are entactogens a new... Neuropsychopharmacol... 1993
Gouzoulis E, von Bardeleb... Neuroendocrine and cardiovascular effects of MDE in healthy volunteers Neuropsychopharmacol... 1993
Cadet JL, Ladenheim B, Ba... CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to... Brain Res 1994
Cadet JL, Ladenheim B, Hi... Superoxide radicals mediate the biochemical effects of methylenedioxym... Synapse 1995
Cerruti C, Sheng P, Laden... Involvement of oxidative and L-arginine-NO pathways in the neurotoxici... Clin Exp Pharmacol P... 1995
Helmlin HJ, Bracher K, Bo... Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolit... J Anal Toxicol 1996
Wickremasinghe M Commentary. Ecstasy and crack cocaine Thorax 1996
Spitzer M, Thimm M, Herml... Increased activation of indirect semantic associations under psilocybi... Biol Psychiatry 1996
Rothe M, Pragst F, Spiege... Hair concentrations and self-reported abuse history of 20 amphetamine ... Forensic Sci Int 1997
Mann H, Ladenheim B, Hira... Differential toxic effects of methamphetamine (METH) and methylenediox... Brain Res 1997
Ensslin HK, Maurer HH, Go... Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... Drug Metab Dispos 1997
Van Cauter E, Plat L, Sch... Simultaneous stimulation of slow-wave sleep and growth hormone secreti... J Clin Invest 1997
Henman AR, Paone D, Des J... From ideology to logistics: the organizational aspects of syringe exch... Subst Use Misuse 1998
Plesan A, Hedman U, Xu XJ... Comparison of ketamine and dextromethorphan in potentiating the antino... Anesth Analg 1998
Gouzoulis-Mayfrank E, Hab... Hallucinogenic drug induced states resemble acute endogenous psychoses... Eur Psychiatry 1998
Henman AR, Paone D, Des J... Injection drug users as social actors: a stigmatized community's parti... AIDS Care 1998
Gouzoulis-Mayfrank E, Her... History, rationale and potential of human experimental hallucinogenic ... Pharmacopsychiatry 1998
Gouzoulis-Mayfrank E, The... Psychopathological, neuroendocrine and autonomic effects of 3,4-methyl... Psychopharmacology (... 1999
Jayanthi S, Ladenheim B, ... Overexpression of human copper/zinc superoxide dismutase in transgenic... Neuroscience 1999
Gouzoulis-Mayfrank E, Sch... Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetami... Neuropsychopharmacol... 1999
Gouzoulis-Mayfrank E, Sch... Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetami... Neuropsychopharmacol... 1999
Grotenhermen F [Some practice-relevant aspects of the pharmacokinetics of THC] Forsch Komplementarm... 1999
Mann JJ, Huang YY, Underw... A serotonin transporter gene promoter polymorphism (5-HTTLPR) and pref... Arch Gen Psychiatry 2000
Quail MT, Weimersheimer P... Abuse of telazol: an animal tranquilizer J Toxicol Clin Toxic... 2001
Spitzer M, Franke B, Walt... Enantio-selective cognitive and brain activation effects of N-ethyl-3,... Neuropharmacology 2001
Decaestecker T, De Letter... Fatal 4-MTA intoxication: development of a liquid chromatographic-tand... J Anal Toxicol 2001
Thiriet N, Ladenheim B, M... Analysis of ecstasy (MDMA)-induced transcriptional responses in the ra... FASEB J 2002
Grotenhermen F Pharmacokinetics and pharmacodynamics of cannabinoids Clin Pharmacokinet 2003
Heim R Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-M... Doctoral Thesis 2003
Buechler J, Schwab M, Mik... Enantioselective quantitation of the ecstasy compound R- and S-N-ethyl... J Chromatogr B Analy... 2003
Marsicano G, Goodenough S... CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 2003
Fantegrossi WE, Woolverto... Behavioral and Neurochemical Consequences of Long-Term Intravenous Sel... Neuropsychopharmacol... 2004
Grotenhermen F How to prevent cannabis-induced psychological distress...in politician... Lancet 2004
Daumann J, Fischermann T,... Proton magnetic resonance spectroscopy in ecstasy (MDMA) users Neurosci Lett 2004
Daumann J Jr, Fischermann... Neural mechanisms of working memory in ecstasy (MDMA) users who contin... Biol Psychiatry 2004
Gouzoulis-Mayfrank E, Fis... Memory performance in polyvalent MDMA (ecstasy) users who continue or ... Drug and Alcohol Dep... 2005
Lee DY, Karnati VV, He M,... Synthesis and in vitro pharmacological studies of new C(2) modified sa... Bioorg Med Chem Lett 2005
Casteele SR, Bouche MP, V... LC-MS/MS in the elucidation of an isomer of the recreational drug meth... J Sep Sci 2005
Lachenmeier DW, Emmert J,... Thujone--cause of absinthism? Forensic Sci Int 2006
Padosch SA, Lachenmeier D... Absinthism: a fictitious 19th century syndrome with present impact Subst Abuse Treat Pr... 2006
Lachenmeier DW, Nathan-Ma... Systematic Misinformation about Thujone in Pre-ban Absinthe Deutsche Lebensmitte... 2007
Cheze M, Deveaux M, Marti... Simultaneous analysis of six amphetamines and analogues in hair, blood... Forensic Sci Int 2007
Lachenmeier DW, Nathan-Ma... Chemical composition of vintage preban absinthe with special reference... J Agric Food Chem 2008
Welsh C, Sherman SG, Tobi... A case of heroin overdose reversed by sublingually administered bupren... Addiction 2008
Meyer MR, Wilhelm J, Pete... Beta-keto amphetamines: studies on the metabolism of the designer drug... Anal Bioanal Chem 2010
Mason K, Cottrell AM, Cor... Ketamine-associated lower urinary tract destruction: a new radiologica... Clin Radiol 2010
Kapp FG, Maurer HH, Auwär... Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna... J Med Toxicol 2011
Hermle L, Ruchsow M, Täsc... [Hallucinogen Persisting Perception Disorder (HPPD) and Flashback Phen... Fortschr Neurol Psyc... 2015
Petri G, Expert P, Turkhe... Homological scaffolds of brain functional networks J R Soc Interface 2015
Csete J, Kamarulzaman A, ... Public health and international drug policy Lancet 2016
Palamar JJ, Acosta P, She... Self-reported use of novel psychoactive substances among attendees of ... Am J Drug Alcohol Ab... 2016
Palamar JJ, Acosta P, Cal... Assessing self-reported use of new psychoactive substances: The impact... Am J Drug Alcohol Ab... 2017
Williams NR, Heifets BD, ... Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor A... Am J Psychiatry 2018
Krieger MS, Goedel WC, Bu... Use of rapid fentanyl test strips among young adults who use drugs Int J Drug Policy 2018
Green TC, Park JN, Gilber... An assessment of the limits of detection, sensitivity and specificity ... International Journa... 2020